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Genetically modified pigs are valuable models of human disease and donors of xenotransplanted organs. Conventional gene 
targeting in pig somatic cells is extremely inefficient. Zinc-finger nuclease (ZFN) technology has been shown to be a powerful 
tool for efficiently inducing mutations in the genome. However, ZFN-mediated targeting in pigs has rarely been achieved. 
Here, we used ZFNs to knock out the porcine α-1,3-galactosyl-transferase (GGTA1) gene, which generates Gal epitopes that 
trigger hyperacute immune rejection in pig-to-human transplantation. Primary pig fibroblasts were transfected with ZFNs tar-
geting the coding region of GGTA1. Eighteen mono-allelic and four biallelic knockout cell clones were obtained after drug se-
lection with efficiencies of 23.4% and 5.2%, respectively. The biallelic cells were used to produce cloned pigs via somatic cell 
nuclear transfer (SCNT). Three GGTA1 null piglets were born, and one knockout primary fibroblast cell line was established 
from a cloned fetus. Gal epitopes on GGTA1 null pig cells were completely eliminated from the cell membrane. Functionally, 
GGTA1 knockout cells were protected from complement-mediated immune attacks when incubated with human serum. This 
study demonstrated that ZFN is an efficient tool in creating gene-modified pigs. GGTA1 null pigs and GGTA1 null fetal fibro-
blasts would benefit research and pig-to-human transplantation. 
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Pigs are considered to be one of the best species to generate 
models of human disease and provide organs for xenotrans-
plantation [1]. Genetically modified pigs have been demon-
strated to successfully mimic human disease symptoms as 
well as to reduce immune rejection in pig-to-human trans- 
plantation [24]. However, traditional gene targeting using 
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homologous recombination (HR) has only been shown to be 
efficient in embryonic stem (ES) cells [5,6]. Unfortunately, 
to date, authentic pig ES cell lines have not been established. 
HR in cultured somatic cells is extremely inefficient, and 
this has become the main barrier in making gene-targeted 
pigs [3,7,8]. Recently, zinc-finger nuclease (ZFN) technol-
ogy was shown to be a revolutionary tool for introducing 
targeted modifications into the genome.  
Xenotransplantation is a potential approach to resolve the 
problem of human graft shortages in clinical allotransplan-
tation. Thus far, pigs are the most appropriate animals for 
organ donation because of their compatible size and physi-
ological characteristics with humans.  
The cell membrane of most mammals presents α-1, 
3-galactosyl (Gal) epitopes, with the exception of humans 
and Old World monkeys [9]. However, there are anti-Gal 
antibodies in human blood. Therefore, transplantation of pig 
organs into humans causes a hyperacute rejection response, 
which is a major barrier for pig-to-human transplantation 
[10–12]. Gal epitopes are catalyzed by α-1, 3-galactosyl- 
transferase (GGTA1). Therefore, to eliminate the xenoanti-
gen, the pig GGTA1 gene has been knocked out using con-
ventional methods [8,13]. Furthermore, solid organs from 
GGTA1 knockout pigs displayed significantly improved 
survival in pig-to-baboon xenotransplantation experiments 
[2,4]. However, HR technology has low efficiency and in-
troduces exogenous drug resistance genes. 
Here, we report the generation of GGTA1 null pigs using 
ZFN technology. 
1  Materials and methods 
1.1  Generation of zinc-finger nucleases 
The ZFN expression plasmids were obtained from Sigma 
Aldrich, USA. A total of three pairs of ZFNs targeting exon 
4 and exon 6 of the porcine GGTA1 gene were designed and 
screened for activity in a yeast MEL-1 reporter assay. Initial 
activity evaluation of ZFNs in mammalian cells was per-
formed using induced pluripotent stem (iPS) cells of pigs 
that were generated previously [14]. Pig iPS cells (5×105) 
were transfected with each pair of ZFN plasmids together 
with a plasmid carrying a puromycin resistance cassette 
using the FuGene HD transfection reagent (Roche, Switzer-
land). After selection with 1 μg mL1 puromycin (Sigma, 
USA) for 3 d, the surviving cells were harvested and as-
sayed by PCR of the GGTA1 locus with primers flanking 
the targeting sites. The PCR product was subcloned into the 
pEASY-Blunt Cloning Vector (Transgene, China) in ac-
cordance with the manufacturer’s protocol. For each ZFN 
set, 50 colonies were picked and sequenced with the M13F 
primer. The targeting frequency was calculated as follows: 
mutant cell%=(number of mutant colonies/50)×100%×2. 
1.2  Cell culture, transfection and selection 
Fetal fibroblasts were isolated from porcine fetuses on day 
35 of gestation as previously described and cultured for 
three passages in Dulbecco’s Modified Eagle Medium 
(DMEM; GIBCO, USA) supplemented with 1% nonessen-
tial amino acids (GIBCO), 2 mmol L1 L-glutamine (Sigma), 
0.1 mmol L1 β-mercaptoethanol, 0.1 mmol L1 sodium 
pyruvate (Sigma-Aldrich), and 15% FBS (Hyclone, USA) 
before transfection. The cells were trypsinized (0.25% 
Trypsin-EDTA, GIBCO), washed with DMEM, and finally 
suspended in 400 μL transfection medium (75% cytosalts 
(120 mmol L1 KCl, 0.15 mmol L1 CaCl2, 10 mmol L1 
K2HPO4; pH 7.6, 5 mmol L
1 MgCl2) and 25% Opti-MEM 
(GIBCO)) containing 7.5 μg of each Set#2 ZFN plasmid 
and 5 μg pCDNA3.1-GFP. Electroporation was performed 
at 300 V for a single 30-ms pulse (ECM2001 Electro Cell 
Manipulator, BTX, USA) in a 2-mm gap cuvette (BTX) 
[15]. After electroporation, the cells were plated into five 
10-cm dishes (NUNC, Denmark) for 2 d of culture in 
DMEM supplemented with 15% FBS, followed by a 
2-week selection with G418 (500 μg mL1). Cell colonies 
were picked using 10 mm×10 mm cloning cylinders (Sig-
ma), passaged, and detected via PCR genotyping. 
1.3  Somatic cell nuclear transfer and generation of 
cloned pigs 
Somatic cell nuclear transfer (SCNT) was performed as 
previously described [16]. Biallelic knockout fibroblasts were 
cultured to sub-confluence before nuclear transfer. NT em-
bryos cultured for 20 or 40 h were surgically transferred into 
surrogates. Gestation was monitored weekly via ultrasound 
starting 24 days after transfer. Two pregnancies were aborted 
on day 35 of gestation to establish fetal fibroblast cell lines 
[17]. The deliveries were performed by cesarean section on 
day 116120 of gestation. Ear tissue from the piglets was 
sampled for genotyping using the primers mentioned above. 
The PCR products were sequenced. Double curves in the 
sequence diagram usually indicate putative mutation. 
1.4  Off-target site prediction 
Off-targeting sites were searched by scanning the porcine 
genome using “The ZFN site,” an online bioinformatic tool. 
The allowed spacing length was set at 5 or 6 bps, and two 
mismatches were permitted per half site of ZFN. 
1.5  Isolectin staining 
A total of 1×105 fibroblasts from 11LW5, G65P2, and G3F1 
were harvested, washed, and incubated in 0.5 mL PBS with 
1.5 μg FITC-conjugated isolectin-B4 (Enzo Life Sciences, 
Switzerland) for 5 min at 37°C. Subsequently, the cells 
were washed with PBS three times, plated in a single well 
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of a 48-well plate, and examined immediately by fluores-
cence microscopy. 
1.6  Complement-mediated lysis assay of porcine fibro-
blasts 
An MTT assay and Trypan blue staining were performed to 
study the susceptibility of GGTA1 null cells from cloned 
piglets and fetuses to lysis by the human complement sys-
tem. Porcine fibroblasts (2×105) were incubated in PBS 
with 10% pooled complement-preserved normal human 
serum (derived from a healthy volunteer) for 6 h. The treat-
ed cells were seeded onto a 96-well plate (NUNC) at 2×104 
cells per well and cultured in DMEM supplemented with 
15% FBS for 8 h. An MTT Cell proliferation and cytotoxi-
city assay kit (Beyotime, China) was used to evaluate cell 
activity in accordance with the manufacturer’s protocol. 
Soluble formazan accumulation was detected with a spec-
trophotometer (SpectraMax M5 Multi-Mode Microplate 
Readers, Molecular Devices, USA) at a wavelength of  
570 nm. Cell survival was calculated as follows: viable 
cell%=(absorptivity of human serum treated cells/absorp- 
tivity of non-treated cells)×100. For the Trypan blue stain-
ing assays, Trypan blue solution (Beyotime) was added to 
the treated cell suspensions at a final concentration of 
0.04%. Three minutes later, both live and dead cells (stained 
as blue) were quantified and the mortality rate was calcu- 
lated as follows: dead cell%=(number of dead cells/number  
of total cells) ×100. 
2  Results 
2.1  Creation of GGTA1 mutated porcine cells 
Three pairs of ZFNs targeting the pig GGTA1 coding region 
were obtained commercially from Sigma Aldrich (Figure 
1A). The efficiency of the ZFNs was tested in pig iPS cells 
previously generated by our laboratory. Only two pairs 
(Set#1 and Set#2) showed DNA cleavage activity, with ef-
ficiencies of 4.0% and 22.2%, respectively (Figure 1B). 
Therefore, the more active pair of ZFN (Set#2) plasmids 
that recognized exon 6 of GGTA1 was used to generate 
gene-targeted fibroblasts. ZFN plasmids together with 
pCDNA3.1-GFP plasmid were transfected into pig fetal 
fibroblasts via electroporation. After selection with G418, a 
total of 95 cell colonies were picked with cloning cylinders 
for further culture. Among them, 77 proliferated sufficiently 
and were therefore genotyped by sequencing the PCR 
product corresponding to the targeting site. We identified 18 
clones carrying different mono-allelic mutations at the ZFN 
targeting site and four biallelic knockout cell clones (Figure 
1CE).  
To address off-targeting events of the ZFNs, an online 
bioinformatics tool, “The ZFN-site,” was used to predict 
potential off-targeting sites by searching the pig genome.  
 
 
Figure 1  ZFN-mediated targeting in pig somatic cells. A, Binding sites (underlined) of the GGTA1 zinc-finger nucleases. B, Efficiency of three sets of 
ZFNs in pig iPS cells by sequencing analysis. C, Generation of GGTA1 mutant cell clones by ZFNs. D, Sequencing diagram of the mutant clone G31 with a 
mono-allelic 4-bp insertion at the ZFN-targeting site. Space between the two ZFN sites is indicated by a red rectangle. The diagram shows a double curve 
after the mutation site. E, Sequencing results of five GGTA1 mutant cell clones. G1 and G31 carry mono-allelic mutations. G3, G12, and G65 are all homol-
ogous biallelic knockout clones. 
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Fortunately, no off-target sites were predicted with the per-
mission of two mismatches per half-site of GGTA1 with 
ZFN Set#2. 
2.2  Generation of GGTA1 knockout piglets by somatic 
cell nuclear transfer 
Three homozygous KO cell clones (G3, G12 and G65) 
(Figure 1E) were used as donor cells for SCNT. A total of 
2093 cloned embryos were transferred into eleven surrogate 
mothers (Table 1). Eight pigs were confirmed pregnant by 
ultrasonography. Among them, one surrogate mother abor- 
ted the pregnancy for unknown reasons. Two were sacri-
ficed, and the fetuses were removed to establish serial 
GGTA1 knockout cell lines. The other five surrogate moth-
ers gave birth to a total of 15 living piglets (Table 1). Se-
quence analysis revealed that only three piglets were 
knockout individuals, derived from cell clones G12 (one 
piglet) and G65 (two piglets) (Figure 2A and B). Unex-
pectedly, all nine piglets derived from cell clone G3 were 
not gene-modified. Therefore, we checked cell clone G3 for 
SCNT and found that the overwhelming majority of cells 
that were originally mutated were replaced by wild-type 
cells (data not shown). It was speculated that after several 
passages of amplification, the wild-type cells mixed with 
the knockout clones and became the predominant popula-
tion due to impaired proliferation of the knockout cells.  
2.3  Generation of fetal fibroblasts from GGTA1 
knockout fetuses 
It is generally considered that a pig requires multiple gene- 
tic modifications to be suitable for xenotransplantation. 
GGTA1 null mutants with modification of other immune- 
related components would make pig organs much more 
compatible with human bodies [1821]. However, initially- 
targeted fibroblasts nearly exhaust their proliferative capac-
ity due to the long time required for drug selection and am-
plification. Therefore, it is necessary to obtain strongly pro- 
liferative GGTA1 null somatic cells from fetuses. In our 
study, two pregnant surrogate mothers were killed at day 35 
(Table 1), and nine morphologically normal fetuses (G3F1-  
Table 1  Cloning results using ZFN modified GGTA1 null cells with number of transferred embryos, pregnant sows, liveborn and mutant piglets 
Surrogate Donor cell line Transferred NT embryos Pregnant Liveborn Mutant piglets 
0412 G3 235 Aborted   
0420-1 G3 177 Fetus removed on day 35 1 (killed fetus) 
0420-2 G3 185 Fetus removed on day 35 0 
0422-1 G3 191    
0422-2 G3 199    
0427-1 G12 194 Delivered 1 1 
0427-2 G12 201 Delivered 3 0 
0428 G3 170 Delivered 3 0 
0506-1 G3 192 Delivered 6 0 
0506-2 G3 192    
0608-1 G65 157 Delivered 2 2 
Total (n=11)  2093 
8/11=72.7% 
Pregnancy rate 
15 4 (including 1 killed fetus) 
 
 
Figure 2  Generation of GGTA1 knockout cloned pigs and primary fibroblasts derived from cloned fetuses. A, DNA and amino acid sequences of GGTA1 
proximal to the ZFN targeting site in the biallelic knockout cell clones used for SCNT. The yellow highlighted region indicates the space of the ZFNs. B, 
Image of GGTA1 null cloned piglets at four weeks of age. C, Primary fibroblasts isolated from the cloned fetus G3F1. Scale bar, 100 μL. 
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G3F9) were obtained, from which primary fibroblasts were 
successfully isolated and cultured (Figure 2C). Sequencing 
analysis confirmed G3F1 as a knockout fetus in accordance 
with the donor cell clone G3 (Figure 2A).  
2.4  Gal epitopes were eliminated in fibroblasts derived 
from GGTA1 null piglets and fetuses 
Isolectin B4 shows high affinity toward alpha galactose on 
cell membranes [22,23]. Hence, FITC-conjugated isolectin 
B4 was used to detect Gal epitopes of GGTA1 mutant por-
cine cells. In our study, isolectin B4 staining showed the 
absence of Gal epitopes on G65P2 and G3F1 cells, which 
were derived from GGTA1 null cloned piglets and fetuses, 
respectively. On the other hand, wild-type primary fibro-
blasts (11LW5) exhibited obvious green fluorescence on 
their cell surfaces, indicating Gal epitopes (Figure 3A). 
2.5  GGTA1 biallelic mutation protects porcine fibro-
blasts from complement-mediated lysis 
To study whether depletion of Gal epitopes prevents cell 
lysis by the human complement system, GGTA1 null fibro-
blasts from cloned piglets (G65P2) and from cloned fetuses 
(G3F1), as well as wild-type fibroblasts (11LW5), were 
treated with complete human serum. Trypan blue staining 
and MTT assays were performed to detect cell survival after 
immune attack. Trypan blue stains dead cells while MTT 
assays label live cells. By treating the cells with a 1:10 di- 
lution of human serum for 6 h, 88.2% of the wild-type cells 
were killed. However, the GGTA1 null cells (G65P2 and  
G3F1) only showed approximately 18% cell death (Figure 
3B). Similarly, the MTT assays also demonstrated that few 
11LW5 cells survived after human serum treatment. On the 
other hand, GGTA1 null fibroblasts showed nearly full ac-
tivity, indicated by an accumulation of formazan (Figure 
3C). These results convincingly showed that the elimination 
of Gal epitopes by ZFN-mediated GGTA1 knockout effi-
ciently protected pig somatic cells from human comple-
ment-mediated lysis. 
3  Discussion 
In this study, we demonstrated that ZFN technology was 
capable of efficiently disrupting GGTA1 gene in porcine 
somatic cells. Moreover, biallelic knockout piglets were 
successfully produced via SCNT using ZFN-targeted cells. 
Fibroblasts derived from GGTA1 null cloned piglets and 
fetuses lacked Gal epitopes and showed dramatic resistance 
against human complement-mediated lysis, as described in 
previous reports. 
Due to their physiological and anatomical similarities 
with humans, pigs are considered to be a better experi-
mental model than rodents and one of the best donors for 
organ transplantation. However, precise genetic modifica-
tion of pigs is quite difficult due to the absence of ES cells, 
which dramatically hampers the use of pigs in biomedical 
research and drug discovery. In our current study, we 
demonstrated that ZFN-mediated targeting has an efficiency 
10000-fold higher than that of conventional HR targeting 
technology. Furthermore, biallelic knockout could be 
achieved in primary cells with a frequency of 5.2%, which  
 
 
Figure 3  Gal epitope detection and complement-mediated lysis of porcine ZFN-GGTA1 knockout fibroblasts. A, Isolectin B4-FITC-staining of fibroblasts 
from wild-type pigs, knockout cloned piglets and fetuses. B, Trypan blue assay of GGTA1 knockout fibroblasts treated with human serum. C, MTT assay of 
GGTA1 knockout fibroblasts treated with human serum. 11LW5 is a wild-type porcine fibroblast line, while G65P2 and G3F1 are fibroblasts derived from 
GGTA1 knockout cloned piglets and fetuses, respectively. 
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means that genetically deficient pigs could be generated 
from a single cloning step. During the process of our study, 
similar progress had been made by other groups, who also 
demonstrated the efficient generation of ZFN-mediated 
GGTA1 knockout pigs via SCNT [24,25]. 
Previous studies found that GGTA1 knockout reduced 
immune rejection, but this strategy could not completely 
eliminate immune rejection in xenotransplantation. Several 
improvements have been made to prolong xenograft survival, 
such as ectopic expression of human complement regulatory 
proteins (CD46, CD55, or CD59). Because of their limited 
proliferation ability, genetically modified pig primary cells 
are difficult to expand for further genetic manipulation. In the 
current study, we isolated primary fibroblasts from GGTA1 
null fetuses. These cells allowed additional genetic modifica-
tion based on GGTA1 knockout and improved our under-
standing of pig-to-human organ transplantation.  
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